ImmunityBio Inc. Common Stock vs Semtech Corporation Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B), while Semtech Corporation Common Stock trades at $189.3 (market cap $17.49B). The key difference: Semtech Corporation Common Stock is the larger of the two by market cap, and Semtech Corporation Common Stock is trading nearer its 52-week high, ImmunityBio Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Semtech Corporation Common Stock for 0 Days on average.
| IBRX | SMTC | |
|---|---|---|
Market Cap | $10.51B | $17.49B |
Volume | 10,445,785 | 4,235,937 |
Sector | Health | Technology |
52-Week High | $11.55 | $197.20 |
52-Week Low | $1.98 | $62.57 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.97B | $17.78B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Semtech develops analog and mixed-signal semiconductors and connectivity products. Its technologies are used in communications, data centers, industrial systems, and IoT devices.
Read more on SMTC →